Lundbeck strikes expanded pact with Eversana to broaden AI scope across US commercial business

A year after unveiling its AI Agency platform, Eversana has reeled in its first publicly named pharma partner with brain disease specialist Lundbeck signing on to use the AI commercialization digs | The partnership builds on previous work and will expand Lundbeck's use of Eversana's AI Agency platform across its U.S. commercial organization, the companies said.